NASDAQ · ELOX
Eloxx Pharmaceuticals, Inc.
$13.45+$0.27 (+2.05%)
Eloxx Pharmaceuticals, Inc.’s quoted price sits in the lower half of its reported 52-week range, 42.52% below the high.
Loading market information…
OTC · OMDD · USD
Stock price
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Ormand Industries Inc’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Ormand Industries Inc engages in the manufacture, sale, and refurbishment of optical supplies. The company is based in Dallas, Texas.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 09:15 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
$13.45+$0.27 (+2.05%)
Eloxx Pharmaceuticals, Inc.’s quoted price sits in the lower half of its reported 52-week range, 42.52% below the high.
$0.00$0.00 (0.0%)
Nutrition Management Services Company’s quoted price sits in the lower half of its reported 52-week range, 98.0% below the high.
$0.00$0.00 (0.0%)
Biocept, Inc.’s quoted price sits in the lower half of its reported 52-week range, 85.0% below the high.
$0.00$0.00 (0.0%)
Verde Science, Inc.’s quoted price sits in the lower half of its reported 52-week range, 80.0% below the high.
$0.00$0.00 (0.0%)
Strategic Global Investments, Inc.’s quoted price sits in the lower half of its reported 52-week range, 90.0% below the high.
$0.00$0.00 (0.0%)
Thoughtful Brands Inc.’s quoted price sits in the lower half of its reported 52-week range, 90.0% below the high.
$0.00$0.00 (0.0%)
Nabriva Therapeutics plc’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
$0.00$0.00 (0.0%)
Plant-Based Investment Corp.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
